Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America..
We partnered with the US Department of Health and Human Services to treat high-risk, nonadmitted coronavirus disease 2019 (COVID-19) patients with bamlanivimab in the Bronx, New York per Emergency Use Authorization criteria. Increasing posttreatment hospitalizations were observed monthly between December 2020 and March 2021 in parallel to the emergence of severe acute respiratory syndrome coronavirus 2 variants in New York City.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Open forum infectious diseases - 8(2021), 8 vom: Aug., Seite ofab313 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cowman, Kelsie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antimicrobial stewardship |
|---|
| Anmerkungen: |
Date Revised 08.11.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/ofid/ofab313 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330012029 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330012029 | ||
| 003 | DE-627 | ||
| 005 | 20231225210356.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ofid/ofab313 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1100.xml |
| 035 | |a (DE-627)NLM330012029 | ||
| 035 | |a (NLM)34458391 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cowman, Kelsie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 08.11.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. | ||
| 520 | |a We partnered with the US Department of Health and Human Services to treat high-risk, nonadmitted coronavirus disease 2019 (COVID-19) patients with bamlanivimab in the Bronx, New York per Emergency Use Authorization criteria. Increasing posttreatment hospitalizations were observed monthly between December 2020 and March 2021 in parallel to the emergence of severe acute respiratory syndrome coronavirus 2 variants in New York City | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 variants | |
| 650 | 4 | |a antimicrobial stewardship | |
| 650 | 4 | |a monoclonal antibodies | |
| 700 | 1 | |a Guo, Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Pirofski, Liise-Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, David |e verfasserin |4 aut | |
| 700 | 1 | |a Bao, Hongkai |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Victor |e verfasserin |4 aut | |
| 700 | 1 | |a Hopkins, Una |e verfasserin |4 aut | |
| 700 | 1 | |a Andrews, Erin |e verfasserin |4 aut | |
| 700 | 1 | |a Hamel, Joseph |e verfasserin |4 aut | |
| 700 | 1 | |a Keller, Marla |e verfasserin |4 aut | |
| 700 | 1 | |a Bellin, Eran |e verfasserin |4 aut | |
| 700 | 1 | |a Thota, Raja |e verfasserin |4 aut | |
| 700 | 1 | |a Davis, Patricia |e verfasserin |4 aut | |
| 700 | 1 | |a Rodriguez, Edwin Torres |e verfasserin |4 aut | |
| 700 | 1 | |a Suthar, Pooja |e verfasserin |4 aut | |
| 700 | 1 | |a Allen, Lauren |e verfasserin |4 aut | |
| 700 | 1 | |a Rossi, James |e verfasserin |4 aut | |
| 700 | 1 | |a Haviland, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Orner, Erika |e verfasserin |4 aut | |
| 700 | 1 | |a Szymczak, Wendy |e verfasserin |4 aut | |
| 700 | 1 | |a Shujauddin, Sadahf |e verfasserin |4 aut | |
| 700 | 1 | |a McCarthy, James |e verfasserin |4 aut | |
| 700 | 1 | |a Binder, Barbara |e verfasserin |4 aut | |
| 700 | 1 | |a Pushparaj, Vanitha |e verfasserin |4 aut | |
| 700 | 1 | |a Bard, Linda |e verfasserin |4 aut | |
| 700 | 1 | |a Pierino, Vincent Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Alsina, Leslie |e verfasserin |4 aut | |
| 700 | 1 | |a Esses, David |e verfasserin |4 aut | |
| 700 | 1 | |a McCaskie, Alicia |e verfasserin |4 aut | |
| 700 | 1 | |a Campbell, Caron |e verfasserin |4 aut | |
| 700 | 1 | |a Madzura, Tabitha |e verfasserin |4 aut | |
| 700 | 1 | |a Wollowitz, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Basset, Kelly |e verfasserin |4 aut | |
| 700 | 1 | |a White, Deborah |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz, Rafael |e verfasserin |4 aut | |
| 700 | 1 | |a Sosnowski, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Nori, Priya |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Open forum infectious diseases |d 2014 |g 8(2021), 8 vom: Aug., Seite ofab313 |w (DE-627)NLM243576811 |x 2328-8957 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2021 |g number:8 |g month:08 |g pages:ofab313 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ofid/ofab313 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2021 |e 8 |c 08 |h ofab313 | ||